# Sarepta Therapeutics, Inc. (SRPT)

Sarepta Therapeutics' Elevidys receives positive attention with Japanese NHI drug price listing and ongoing clinical trial for Huntington's Disease. Social media buzz highlights potential recovery and investor interest.

### About Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. is a healthcare company focused on gene therapy for rare diseases.  
Sarepta Therapeutics, Inc. uses the ticker $SRPT for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Sarepta Therapeutics, Inc. (SRPT) posts created is up 58.35% from the previous month.

### Price: $17.80
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics-inc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics-inc/time-series/close.tsv)  
The stock price has experienced a significant downturn due to missed Q4 Elevidys sales targets and regulatory headwinds. However, recent social media sentiment indicates expectations of a recovery, fueled by anticipated data releases and positive sales reports, with some users adding to their positions.  

24-Hour: 1.49%
7-Day: -3.94%
30-Day: -15.81%

1-Year High: $108.40 on 2025-02-20  
1-Year Low: $11.90 on 2025-07-25  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics-inc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics-inc/time-series/alt_rank.tsv)  
Sarepta Therapeutics, Inc. (SRPT) is currently AltRank #863 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +476  
[--] Month: [---] +262  
[--] Months: [---] +715  
[--] Year: [---] +674  
1-Year High: [-----] on 2025-03-16  
1-Year Low: [--] on 2025-03-19  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics-inc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics-inc/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +1  
[--] Month: [--] +15  
[--] Months: [--] +9  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-10-02  
1-Year Low: [--] on 2025-03-09  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics-inc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics-inc/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [-------] -11%  
[--] Month: [---------] +44%  
[--] Months: [----------] -46%  
[--] Year: [----------] +63%  
1-Year High: [---------] on 2025-07-18  
1-Year Low: [-----] on 2025-03-09  

Engagements by network (24h):
News: [--]
Reddit: [--]
X: [------]
YouTube: [--]
TikTok: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics-inc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics-inc/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [---] -20%  
[--] Month: [-----] +37%  
[--] Months: [------] -59%  
[--] Year: [------] +326%  
1-Year High: [-----] on 2025-07-18  
1-Year Low: [--] on 2025-12-07  

Mentions by network (24h):
News: [--]
Reddit: [--]
X: [---]
YouTube: [--]
TikTok: [--]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics-inc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics-inc/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning Sarepta Therapeutics, Inc. (SRPT) in the last [--] hours which is up 70% from [---] in the previous [--] hours
Daily Average: [---]  
[--] Week: [---] -21%  
[--] Month: [---] +23%  
[--] Months: [-----] -72%  
[--] Year: [------] +690%  
1-Year High: [-----] on 2025-07-17  
1-Year Low: [--] on 2025-02-17  

The most influential creators that mention Sarepta Therapeutics, Inc. in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Nationofhorror](/creator/twitter/Nationofhorror)   | [--]    | [------]    | [--]    | [-----]       |
| [@SU_pharma](/creator/twitter/SU_pharma)             | [--]    | [-----]     | [--]     | [-----]       |
| [@yachmod](/creator/twitter/yachmod)                 | [--]    | [---]       | [--]    | [-----]       |
| [@n_hatami](/creator/twitter/n_hatami)               | [--]    | [---]       | [--]     | [---]         |
| [@newerraa](/creator/twitter/newerraa)               | [--]    | [---]       | [--]     | [---]         |
| [@TequilaVernetti](/creator/twitter/TequilaVernetti) | [--]    | [--]        | [--]     | [---]         |
| [@TOWiU2](/creator/twitter/TOWiU2)                   | [--]    | [-----]     | [--]     | [---]         |
| [@ParadiseTraderr](/creator/twitter/ParadiseTraderr) | [--]    | [---]       | [--]     | [---]         |
| [@gollev66036](/creator/twitter/gollev66036)         | [--]    | [--]         | [--]     | [---]         |
| [@SMALLCAPSAXIS](/creator/twitter/SMALLCAPSAXIS)     | [--]   | [---]       | [--]     | [---]         |

[View More](/list/creators/sarepta-therapeutics-inc/100)
  
  
### Sentiment: 71%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics-inc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics-inc/time-series/sentiment.tsv)  
Current Value: 71%  
Daily Average: 71%  
[--] Week: 82% +4%  
[--] Month: 66% -4%  
[--] Months: 66% -9%  
[--] Year: 66% -15%  
1-Year High: 97% on 2025-07-04  
1-Year Low: 34% on 2025-05-07  

Most Supportive Themes:
- Elevidys Potential: (55%) Analysts are optimistic about Sarepta Therapeutics' potential for gene therapy, particularly Elevidys, citing potential upside and long-term value.
  
Most Critical Themes:
- Regulatory Concerns: (10%) Concerns about regulatory issues and market volatility following two patient deaths linked to Sarepta's gene therapy.
  
  
  
### Social Dominance: 0.023%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics-inc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics-inc/time-series/social_dominance.tsv)  
Current Value: 0.023%  
Daily Average: 0.074%  
[--] Week: 0.023% +0.00141%  
[--] Month: 0.03% -0.014%  
[--] Months: 0.03% -0.049%  
[--] Year: 0.03% -0.017%  
1-Year High: 0.576% on 2025-07-18  
1-Year Low: 0.014% on 2025-12-06  
  
  
### Market Dominance: 0.0021%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics-inc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics-inc/time-series/market_dominance.tsv)  
Current Value: 0.0021%  
Daily Average: 0%  
1-Year High: 0.232% on 2025-03-31  
1-Year Low: 0.0015% on 2025-07-25  
  
  
### Market Cap: $1,850,541,722
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics-inc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics-inc/time-series/market_cap.tsv)  
Current Value: $1,850,541,722  
Daily Average: $3,298,442,643  
[--] Week: $1,850,541,722 -4.60%  
[--] Month: $1,850,541,722 -17%  
[--] Months: $1,850,541,722 -9.80%  
[--] Year: $1,850,541,722 -84%  
1-Year High: $10,519,247,034 on 2025-02-20  
1-Year Low: $1,172,444,992 on 2025-07-25  

### Top Sarepta Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$SRPT @EMA_News Here is some help @Roche for Elevidys Identify serious unmet need ✔ Generate strong early data ✔ Apply for EMA PRIME in IRIS Engage in early frequent EMA advice Submit optimized MAA for faster review You got this just try"  
[X Link](https://x.com/yachmod/status/2022477949619048797) [@yachmod](/creator/x/yachmod) 2026-02-14T01:08Z [---] followers, [---] engagements


"Verification and assessment from Grok about $srpt @commonsenseplay https://grok.com/share/c2hhcmQtMw_c28a23ba-f71b-4927-9c17-7140c4f8c615 https://grok.com/share/c2hhcmQtMw_c28a23ba-f71b-4927-9c17-7140c4f8c615"  
[X Link](https://x.com/jiasu666/status/2022451738524127291) [@jiasu666](/creator/x/jiasu666) 2026-02-13T23:24Z [---] followers, [---] engagements


"@newerraa Good news G filing and do not see much on the shorting side from them. Like to see hedge funds go long much more positive than Blackrock owning 13m shs. Those shares are so spread out over funds. Hopefully AQR will ratchet it up. Need more momentum $SRPT"  
[X Link](https://x.com/yachmod/status/2022435936244564074) [@yachmod](/creator/x/yachmod) 2026-02-13T22:21Z [---] followers, [---] engagements


"@LTbioinvestor $VKTX $SRPT $CYTK $IDYA Week [--] after Poll:"  
[X Link](https://x.com/TOWiU2/status/2022432922314375625) [@TOWiU2](/creator/x/TOWiU2) 2026-02-13T22:09Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing